Sharescart Research Club logo

Transchem Overview

Transchem Ltd is an Indian company engaged in the manufacturing, trading, and supply of industrial chemicals and chemical solutions. Its products cater to industries such as paints and coatings, plastics, textiles, construction, and agriculture. The company focuses on quality production, consistency, and meeting client specifications. Through its operations, Transchem aims to serve diverse industrial sectors and expand its presence in the chemical manufacturing and supply market

Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

Transchem Key Financials

Market Cap ₹205 Cr.

Stock P/E 39.3

P/B 2.5

Current Price ₹167.9

Book Value ₹ 66.2

Face Value 10

52W High ₹194.3

Dividend Yield 0%

52W Low ₹ 31.1

Transchem Share Price

₹ | |

Volume
Price

Transchem Quarterly Price

Show Value Show %

Transchem Peer Comparison

Transchem Quarterly Results

#(Fig in Cr.) Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Net Sales 0 0 0 0 0 0 0 2 0 0
Other Income 2 2 2 2 2 2 2 2 2 2
Total Income 2 2 2 3 2 2 2 4 2 2
Total Expenditure 0 0 0 1 0 0 1 3 0 1
Operating Profit 1 1 2 2 2 2 2 1 1 1
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 1 1 2 2 2 2 2 1 1 1
Provision for Tax 0 0 0 0 1 0 0 0 0 0
Profit After Tax 1 1 1 1 2 1 1 1 1 1
Adjustments 0 0 -0 0 0 0 -0 0 0 0
Profit After Adjustments 1 1 1 1 2 1 1 1 1 1
Adjusted Earnings Per Share 0.7 0.8 0.9 1 1.4 1.2 1.1 0.6 0.8 0.6

Transchem Profit & Loss

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 0 0 0 0 0 0 22 0 0 0 3 2
Other Income 2 2 2 2 3 3 4 7 4 7 9 8
Total Income 2 2 2 2 3 3 27 7 4 8 11 10
Total Expenditure 1 1 1 2 1 1 2 3 2 2 4 5
Operating Profit 1 1 1 0 2 1 25 4 3 6 7 5
Interest 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 1 1 1 1 1 1 0 0 0 0 0 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 0 0 -0 -1 1 1 25 4 3 6 7 5
Provision for Tax 0 0 0 1 0 0 1 1 1 1 2 0
Profit After Tax 0 0 -0 -1 0 0 24 3 1 4 5 4
Adjustments 0 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 0 0 -0 -1 0 0 24 3 1 4 5 4
Adjusted Earnings Per Share 0.1 0 -0.2 -1 0.2 0.3 19.7 2.3 1 3.4 4.3 3.1

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 0% 0% 0% 0%
Operating Profit CAGR 17% 21% 48% 21%
PAT CAGR 25% 19% 0% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 251% 90% 55% 26%
ROE Average 7% 5% 13% 6%
ROCE Average 9% 7% 15% 7%

Transchem Balance Sheet

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 38 38 38 37 38 37 63 66 66 76 79
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities -0 -0 -1 0 0 0 0 0 0 0 0
Total Current Liabilities 0 0 0 0 0 0 0 0 0 0 0
Total Liabilities 38 38 38 37 38 37 63 67 66 76 80
Fixed Assets 8 7 6 5 4 4 0 0 0 0 0
Other Non-Current Assets 2 2 2 2 6 4 9 9 8 9 2
Total Current Assets 27 28 29 30 28 30 55 58 58 67 78
Total Assets 38 38 38 37 38 37 63 67 66 76 80

Transchem Cash Flow

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 1 0 1 0 0 16 16 12 34 34 0
Cash Flow from Operating Activities 1 1 1 -20 10 -1 -28 22 1 -39 36
Cash Flow from Investing Activities -1 -0 -2 20 6 1 23 1 -1 5 6
Cash Flow from Financing Activities 0 0 0 0 0 0 0 0 0 0 0
Net Cash Inflow / Outflow -0 1 -1 -0 16 0 -5 23 0 -34 42
Closing Cash & Cash Equivalent 0 1 0 0 16 16 12 34 34 0 42

Transchem Ratios

# Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 0.1 0.04 -0.18 -0.97 0.25 0.33 19.73 2.34 1.01 3.43 4.27
CEPS(Rs) 0.97 0.87 0.65 -0.18 0.9 0.8 19.83 2.35 1.02 3.44 4.27
DPS(Rs) 0 0 0 0 0 0 0 0 0 0 0
Book NAV/Share(Rs) 31.33 31.37 31.04 30.07 31.03 30.04 51.42 54.17 53.79 61.8 64.8
Core EBITDA Margin(%) 0 0 0 0 0 0 91.37 0 0 -423.39 -55.65
EBIT Margin(%) 0 0 0 0 0 0 110.29 0 0 1378.78 268.51
Pre Tax Margin(%) 0 0 0 0 0 0 110.29 0 0 1378.78 268.51
PAT Margin (%) 0 0 0 0 0 0 107.53 0 0 1025.22 198.67
Cash Profit Margin (%) 0 0 0 0 0 0 108.08 0 0 1027.2 198.89
ROA(%) 0.31 0.12 -0.58 -3.19 0.81 1.09 48.07 4.4 1.86 5.9 6.7
ROE(%) 0.31 0.12 -0.57 -3.18 0.82 1.1 48.44 4.44 1.87 5.94 6.74
ROCE(%) 0.31 0.12 -0.57 -1.47 2.07 2.12 49.69 6.05 3.79 7.99 9.12
Receivable days 0 0 0 0 0 0 0 0 0 365 216.4
Inventory Days 0 0 0 0 0 0 1.24 0 0 0 0
Payable days 0 0 0 0 0 0 0 0 0 0 19.14
PER(x) 229.3 458.12 0 0 95.3 48.57 0.85 9.39 18.71 8.17 7.8
Price/Book(x) 0.71 0.56 0.72 1.08 0.77 0.54 0.32 0.41 0.35 0.45 0.51
Dividend Yield(%) 0 0 0 0 0 0 0 0 0 0 0
EV/Net Sales(x) 0 0 0 0 0 0 0.39 0 0 83.03 -0.6
EV/Core EBITDA(x) 22.38 18.96 34.03 94.22 8.09 2.58 0.35 -1.86 -4.52 6.01 -0.22
Net Sales Growth(%) 0 0 0 0 0 0 0 -100 0 0 541.56
EBIT Growth(%) 116.31 -60.5 -566.44 -151.42 241.02 2.29 3024.2 -84.22 -35.91 125.7 24.94
PAT Growth(%) 114.7 -60.42 -567.52 -443.75 125.64 34.27 5796.5 -88.12 -56.87 239.78 24.33
EPS Growth(%) 114.7 -60.46 -567.8 -443.88 125.64 34.27 5796.74 -88.12 -56.87 239.78 24.32
Debt/Equity(x) 0 0 0 0 0 0 0 0 0 0 0
Current Ratio(x) 521.53 1032.53 830.38 851.29 127.78 309.89 213.97 207.08 644.8 140.56 257.86
Quick Ratio(x) 497.08 996.9 805 842.16 126.37 309 213.7 206.54 644.8 140.56 257.86
Interest Cover(x) 272.27 648.24 -1298.17 -2086.67 0 2586.86 0 0 4174.5 0 0
Total Debt/Mcap(x) 0 0 0 0 0 0 0 0 0 0 0

Transchem Shareholding Pattern

# Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Promoter 51.68 51.68 51.68 51.68 51.68 51.68 56.45 56.45 56.45 56.45
FII 0 0 0 0 0 0 0 0 0 0
DII 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03
Public 48.29 48.29 48.29 48.29 48.29 48.29 43.52 43.52 43.52 43.52
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Transchem News

Transchem Pros & Cons

Pros

  • Company is almost debt free.

Cons

  • Company has a low return on equity of 5% over the last 3 years.
  • Debtor days have increased from 0 to 19.14days.
  • Earnings include an other income of Rs. 9 Cr.
whatsapp